WASHINGTON – Patient gender was the only factor that significantly affected stroke risk during the first year following transcatheter aortic valve replacement, according to an analysis of data from...
LIVERPOOL, ENGLAND – A new analysis of data from the British Society for Rheumatology Biologics Registers’ Rheumatoid Arthritis Register confirms that anti–tumor necrosis factor treatment decreases...
LIVERPOOL, ENGLAND – A new analysis of data from the British Society for Rheumatology Biologics Registers’ Rheumatoid Arthritis Register confirms that anti–tumor necrosis factor treatment decreases...
PARIS – Greater walking disability is an independent predictor of all-cause death and major cardiovascular events in patients with symptomatic hip or knee osteoarthritis, according to a...
PARIS – Greater walking disability is an independent predictor of all-cause death and major cardiovascular events in patients with symptomatic hip or knee osteoarthritis, according to a...
About one-third of heart disease deaths and one-fifth of cancer deaths could be prevented if overall U.S. death rates were the same as those in the states with the lowest rates, the Centers for...
Evidence is insufficient to support lung cancer screening with low-dose computed tomography in the Medicare population, members of the Medicare Evidence Development and Coverage Advisory Committee...
Among African American men with abnormal prostate-specific antigen levels or abnormal findings on digital rectal examination of the prostate, biopsies are more likely to detect prostate cancer in...
Oral budesonide is effective and safe for short-term treatment of collagenous colitis.
Indeed, the finding supports the recent recommendation by the European Microscopic Colitis Group to make...
There is no significant difference between infliximab and adalimumab in Crohn’s disease, reported Dr. Mark T. Osterman and his colleagues in the May 1 issue of Clinical Gastroenterology and...